India
COVID prompts another milestone, as India clears first DNA vaccine
Phil Taylor
coronavirus, COVID-19, COVID-19 vaccine, dna vaccine, India, regulatory approval, ZyCOV-D, Zydus Cadila
0 Comment
Ocugen preps filings for COVID-19 vaccine Covaxin on new data
Phil Taylor
Bharat Biotech, coronavirus, COVID-19, COVID-19 vaccine, India, Ocugen
0 Comment
Zydus Cadila nears world-first human plasmid DNA vaccine approval
Phil Taylor
coronavirus, COVID-19, COVID-19 vaccine, dna vaccine, India, ZyCOV-D, Zydus Cadila
0 Comment
As India battles COVID, Qure.ai deploys AI diagnostic for hard-pressed doctors
Phil Taylor
artificial intelligence, coronavirus, COVID-19, diagnostic, digital, digital health, India, Qure.ai, radiology
0 Comment
Digital/ Views & Analysis/ Views and analysis
Geopolitical uncertainty grips digital health investors
mike.hammerton@pharmaphorum.com
asia, China, digital health, Galen Growth Asia, India, investment
0 Comment
Articles/ Healthcare/ Pharma Market Access/ Views and analysis
Six factors shaping healthcare in emerging markets
Linda Banks
China, emerging markets, healthcare, India, market access, patients, Russia
0 Comment
The factors shaping the healthcare landscape in emerging markets.
Articles/ Clinical/ R&D/ Views and analysis
Regulatory timelines in the Asia-Pacific
Linda Banks
Asia-Pacific, Australia, China, clinical trials, Hong Kong, India, Japan, Malaysia, New Zealand, regulation, regulatory approval, Singapore, South Korea, Taiwan
0 Comment
Snapshot of clinical trial application processes in the region.
Articles/ R&D/ Views and analysis
India improves processes for clinical trials
Linda Banks
AV recording, clinical trials, India, patients
0 Comment